Eli Lilly's Weight-Loss Edge: The Mounjaro Moment Okay, folks, buckle up. I’ve been watching the weight-loss drug space with a hawk's eye, and something significant just happened. Eli Lilly (LLY) is surging while Novo Nordisk (NVO), its maj...